This website uses cookies to enhance the user experience.
||
UNILABS LABORATORIEMEDISIN AS

UNILABS LABORATORIEMEDISIN AS935 439 035

Laboratory
Limited company
Silurveien 2 0380 OSLO, Norge
Health and social
/ Laboratory
/ 86.906 Medical laboratories

UNILABS LABORATORIEMEDISIN AS

Keywords

x-ray institutesblood banks

Links

Organization

CEO
KK

Kjetil Kollstad1973

Chairman of the board
KK

Kjetil Kollstad1973

Years since formation
30 years
since Feb 19, 1995
Type
Limited company
VAT registered
Yes
Number of employees
24

Ownership

Number of shares and share classes
358
1 share class
Total number of shareholders
1
company
Belongs to group of

Financials

Total operating income 2024
204,995,171
NOK
Annual total result 2024
11,006,474
NOK
Total equity 2024
48,436,819
NOK
Last update: Aug 12, 2025

Management

Management / administration

NameRoleShares
KK

Kjetil Kollstad

1973

Managing Director/CEO-

Board

NameRoleShares
IM

Ida Malene Ørsvik

1988

Board Member-
SB

Shalinee Basak

1985

Board Member-
EG

Eskil Gulli Hanssen

1970

Board Member-
HJ

Hilde Jensen Tørresen

1989

Alternate Member-
JH

June Hanssen

1994

Alternate Member-
KK

Kjetil Kollstad

1973

Chairman-
FH

Fredrik Hoff Eriksen

1986

Board Member-

Others

NameRoleShares
P
PRICEWATERHOUSECOOPERS AS
Auditor-
Last update: Jun 12, 2025

Ownership

Company shareholders

NameShare classTotal number of sharesShare
U
UNILABS NORGE AS
Ordinary shares
358
100 %
Last update: Jun 2, 2025

Group structure

  • UNILABS NORGE AS
    Total operating income 2024: NOK 635,496,147
    Operating profit 2024: NOK 85,652,303
    Employees: 278

Financials

in NOK

Summary

Year2024202320222021
Total operating income
204,995,171
159,671,947
153,502,604
173,548,725
Annual Total Result
11,006,474
1,569,766
3,407,614
7,152,613
Total assets
132,117,350
109,499,213
113,991,398
135,947,263
Total liabilities
83,680,531
72,068,868
78,130,818
103,494,297
Total equity
48,436,819
37,430,346
35,860,580
32,452,966

P&L

Year2024202320222021
Total operating income
204,995,171
159,671,947
153,502,604
173,548,725
Total operating costs
189,561,781
155,902,472
146,574,041
162,832,939
Operating result
15,433,390
3,769,475
6,928,563
10,715,786
Financial income/costs
-1,661,236
-1,880,455
-2,723,209
-1,647,358
Profit before tax
13,772,155
1,889,020
4,205,354
9,068,428
Total tax & extraordinary income/cost
2,765,681
319,254
797,740
1,915,815
Annual Total Result
11,006,474
1,569,766
3,407,614
7,152,613

Balance overview

Year2024202320222021
Total fixed assets
61,099,620
67,958,390
68,434,337
75,083,828
Total current assets
71,017,730
41,540,824
45,557,062
60,863,434
Total assets
132,117,350
109,499,213
113,991,398
135,947,263
Short term debt
54,799,144
41,285,400
41,896,617
47,495,616
Long term debt
28,881,386
30,783,468
36,234,202
55,998,681
Total liabilities
83,680,531
72,068,868
78,130,818
103,494,297
Contributed capital
11,745,003
11,745,003
11,745,003
11,745,003
Retained earnings
36,691,817
25,685,343
24,115,577
20,707,963
Total equity
48,436,819
37,430,346
35,860,580
32,452,966
Total equity and liabilities
132,117,350
109,499,213
113,991,398
135,947,263

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
Q
Main industrial area
Human health and social work activities
86
Activity
Human health activities
86.9
Main industrial group
Other human health activities
86.90
Industrial group
Other human health activities
86.906
Industrial group
Medical laboratories